After years investing at the intersection of AI and biology, I’ve never been more convinced that we’re entering a new era: one where biology becomes a digital system. Excited to share my latest article: “The Digital Bio Revolution: Transforming Healthcare” on Business Insider. From AI-designed drugs to immune system twins and mRNA programming, the speed of innovation is accelerating. At FoundersX Ventures, we’re proud to back founders building this future: 1910, Kernal Biologics, Glyphic Biotechnologies, Omniscope, and Zafrens. This isn’t just incremental progress, it’s a reimagining of biology itself, and the foundation of a more efficient, equitable, and sustainable healthcare system. 🔗 Read the full article here: https://lnkd.in/eZ9mfM3a #DigitalBio #AI #DeepTech #Biotech #DrugDiscovery #HealthcareRevolution #Healthcare Helen H. Liang, PhD Sizi Chen Tristan Staschik Murray Newlands Tor Parawell Tom Kosnik Vijay Vaswani Nitesh Shroff Jen Asher, Ph.D. Josh Yang Swamy Vijayan
Emily Pappas
1w
Fascinating perspective on biology's digital transformation, Leo. The portfolio companies you mentioned are tackling some incredibly complex challenges. What excites you most about mRNA programming's potential?
Leo Cui, Ph.D., CFA your scientific knowledge and vision is clear in this srticle. Thank you for being an innovator.